https://www.thebodypro.com/article/dolutegravir-minimalism-a-top-hiv-clinical-develop
Dolutegravir (Tivicay)

Dolutegravir Minimalism: A Top HIV Clinical Development of 2015

    Viral Supression at Week 24
    David Alain Wohl, M.D.

    David Alain Wohl, M.D.

    David Alain Wohl, M.D., is a professor at the University of North Carolina, site leader of the UNC AIDS Clinical Trials Unit at Chapel Hill, director of the North Carolina AETC, and co-director of HIV services for the NC state prison system.